Release of soluble CD40 ligand after platelet activation: Studies on the solubilization phaseOTTERDAL, Kari; PEDERSEN, Turid Margrethe; SOLUM, Nils Olav et al.Thrombosis research. 2004, Vol 114, Num 3, pp 167-177, issn 0049-3848, 11 p.Article

Neutrophil CD40 enhances platelet-mediated inflammationVANICHAKARN, Pantila; BLAIR, Price; WU, Cindy et al.Thrombosis research. 2008, Vol 122, Num 3, pp 346-358, issn 0049-3848, 13 p.Article

Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseasesGOULES, Andreas; TZIOUFAS, Athanasios G; MANOUSAKIS, Menelaos N et al.Journal of autoimmunity (Print). 2006, Vol 26, Num 3, pp 165-171, issn 0896-8411, 7 p.Article

Enhanced soluble cd40l in patients with the metabolic syndrome : relationship with in vivo thrombin generationANGELICO, F; ALESSANDRI, C; FERRO, D et al.Diabetologia (Berlin). 2006, Vol 49, Num 6, pp 1169-1174, issn 0012-186X, 6 p.Article

Statins discontinuation in compliant chronic users induces atherothrombotic profile despite baseline clinical setting and treatmentsPUCCETTI, Luca; LAURA PASQUI, Anna; SCARPINI, Francesca et al.International journal of cardiology. 2011, Vol 153, Num 3, pp 328-329, issn 0167-5273, 2 p.Article

Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromesTOUSOULIS, D; ANTONIADES, C; STEFANADIS, C et al.European journal of clinical investigation. 2007, Vol 37, Num 8, pp 623-628, issn 0014-2972, 6 p.Article

Impact of residual renal function and HCV seropositivity on plasma CD40/CD40L system and oxidative status in haemodialysis patientsPAWLAK, Krystyna; MYSLIWIEC, Michal; PAWLAK, Dariusz et al.Clinical biochemistry. 2010, Vol 43, Num 18, pp 1393-1398, issn 0009-9120, 6 p.Article

Soluble CD40L in patients with morbid obesity : significant reduction after bariatric surgerySCHERNTHANER, G.-H; KOPP, H.-P; KRZYZANOWSKA, K et al.European journal of clinical investigation. 2006, Vol 36, Num 6, pp 395-401, issn 0014-2972, 7 p.Article

Increased soluble CD40L levels are reduced by long-term simvastatin treatment in peritoneally dialyzed patientsMALYSZKO, Jolanta; MALYSZKO, Jacek S; HRYSZKO, Tomasz et al.Blood coagulation & fibrinolysis. 2004, Vol 15, Num 6, pp 463-467, issn 0957-5235, 5 p.Article

Mechanism of collagen-induced release of 5-HT, PDGF-AB and sCD40L from human platelets: Role of HSP27 phosphorylation via p44/p42 MAPKKATO, Hisaaki; ADACHI, Seiji; KOZAWA, Osamu et al.Thrombosis research. 2010, Vol 126, Num 1, pp 39-43, issn 0049-3848, 5 p.Article

Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver diseaseSOOKOIAN, Silvia; CASTANO, Gustavo O; BURGUENO, Adriana L et al.Atherosclerosis. 2010, Vol 209, Num 2, pp 585-591, issn 0021-9150, 7 p.Article

Polycystic ovary syndrome is associated with elevated plasma soluble CD40 ligand, a marker of coronary artery diseaseOKTEM, Mesut; OZCIMEN, Emel Ebru; UCKUYU, Ayla et al.Fertility and sterility. 2009, Vol 91, Num 6, pp 2545-2550, issn 0015-0282, 6 p.Article

Aspirin failure course during exercise and its connection with soluble CD40LKULICZKOWSKI, Wiktor; KOBUSIAK-PROKOPOWICZ, Malgorzata; PRAJS, Iwona et al.Thrombosis research. 2007, Vol 119, Num 6, pp 679-686, issn 0049-3848, 8 p.Article

Signal peptide-CUB-EGF domain-containing protein 1 (SCUBE1) level in hemodialysis patients and parameters affecting that levelULUSOY, Sukru; OZKAN, Gulsum; MENTESE, Ahmet et al.Clinical biochemistry. 2012, Vol 45, Num 16-17, pp 1444-1449, issn 0009-9120, 6 p.Article

BETTER COGNITIVE AND PHYSICAL PERFORMANCE IS ASSOCIATED WITH HIGHER BLOOD PRESSURE IN CENTENARIANSSZEWIECZEK, J; DULAWA, J; GMINSKI, J et al.The Journal of nutrition, health & aging. 2011, Vol 15, Num 8, pp 618-622, issn 1279-7707, 5 p.Article

Platelet activation in acute, decompensated congestive heart failureCHUNG, Irene; CHOUDHURY, Anirban; LIP, Gregory Y. H et al.Thrombosis research. 2007, Vol 120, Num 5, pp 709-713, issn 0049-3848, 5 p.Article

Soluble CD40 Ligand Predicts Ischemic Stroke and Myocardial Infarction in Patients With Nonvalvular Atrial FibrillationFERRO, Domenico; LOFFREDO, Lorenzo; POLIMENI, Licia et al.Arteriosclerosis, thrombosis, and vascular biology. 2007, Vol 27, Num 12, pp 2763-2768, issn 1079-5642, 6 p.Article

Fetal bradycardia following intrauterine platelet transfusion: might elevated levels of donor soluble CD40 ligand play a role?HASAN FEHMI YAZICIOGLU; HARTWIG, Dirk; VON WITZLEBEN-SCHÜRHOLZ, Esther et al.Acta obstetricia et gynecologica Scandinavica. 2004, Vol 83, Num 9, pp 868-869, issn 0001-6349, 2 p.Article

Prevention of Non-immune Mediated Transfusion-related Acute Lung Injury; from Blood Bank to Patient : Preventive and Therapeutic Strategies for Transfusion-Related Acute Lung InjuryBRUGGEN, Robin Van; DE KORTE, Dirk.Current pharmaceutical design (Print). 2012, Vol 18, Num 22, pp 3249-3254, issn 1381-6128, 6 p.Article

Short-term hormone therapy improves sCD40L and endothelial function in early menopausal women: Potential role of estrogen receptor polymorphismsBECHLIOULIS, Aris; NAKA, Katerina K; GEORGIOU, Ioannis et al.Maturitas (Amsterdam). 2012, Vol 71, Num 4, pp 389-395, issn 0378-5122, 7 p.Article

Combined effects of klotho and soluble CD40 ligand on A549 lung cancer cellsXUELI WANG; BO CHEN; WEI XU et al.Oncology reports. 2011, Vol 25, Num 5, pp 1465-1472, issn 1021-335X, 8 p.Article

The CD40-CD40L system in cardiovascular diseasePAMUKCU, Burak; LIP, GregorYY H; SNEZHITSKIY, Viktor et al.Annals of medicine (Helsinki). 2011, Vol 43, Num 5-6, pp 331-340, issn 0785-3890, 10 p.Article

Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditionsRIONDINO, Silvia; MARTINI, Francesca; LA FARINA, Francesca et al.Clinical biochemistry. 2010, Vol 43, Num 7-8, pp 666-670, issn 0009-9120, 5 p.Article

Premature labor : a state of platelet activation?EREZ, Offer; ROMEROI, Roberto; CHONG JAI KIM et al.Journal of perinatal medicine. 2008, Vol 36, Num 5, pp 377-387, issn 0300-5577, 11 p.Article

The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity c-reactive proteinGULDIKEN, Sibel; DEMIR, Muzaffer; ARIKAN, Ender et al.Thrombosis research. 2007, Vol 119, Num 1, pp 79-84, issn 0049-3848, 6 p.Article